ANI Pharma Launches Carbamazepine ER Capsules in US
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
DUBLIN, Ireland, April 9, 2026 Jazz Pharmaceuticals plc has announced the presentation of six scientific abstracts, including one oral...
Boston, USA & Shanghai, China – March 9, 2026 Rapport Therapeutics and Tenacia Biotechnology have announced a strategic collaboration...
February 24, 2026 – Pittsburgh, Pennsylvania, USA Consegna Pharma, Inc. has announced that the U.S. Food and Drug Administration...
February 24, 2026 – Mumbai, India & Naples, Florida, USA Global pharmaceutical leader Lupin Limited has announced that it...
MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 — Global pharmaceutical company Lupin Limited announced the U.S. launch of...
Shanghai, China – September 11, 2025 – Shanghai Zhimeng Biopharma, Inc. today announced that its investigational therapy CB03-154, a...
